A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Conditions:   Kaposiform Hemangioendothelioma (KHE);   Kasabach-Merritt Syndrome;   Tufted AngiomaInterventions:   Drug: Vincristine;   Drug: SirolimusSponsors:   Children's Hospital Medical Center, Cincinnati;   PfizerRecruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials